Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Chemotherapy in High-grade, Operable, Non-metastatic Osteosarcoma
NCT02273583Phase 2Unknown
- Sponsor
- GRAACC
- Start
- May 2006
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, methotrexate in osteosarcoma (OS), sponsored by GRAACC. Status: unknown.
02
Drugs
cyclophosphamidemethotrexate
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT02273583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273583.